![](/img/cover-not-exists.png)
1183PDAdoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours
Butler, M O, Sotov, V, Saibil, S, Bonilla, L, Boross-Harmer, S, Fyrsta, M, Gray, D, Nelles, M, Le, M, Lemiashkova, D, Liu, D, Sacher, A G, Trang, A, Vakili, K, As, B Van, Scheid, E, Nguyen, L, TakahasVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.009
Date:
October, 2019
File:
PDF, 78 KB
2019